KOTA ARIMA

Affiliation and department：
Papers (54)：

Kota Arima, Masaki Ohmuraya, Keisuke Miyake, Mayu Koiwa, Tomoyuki Uchihara, Daisuke Izumi, Feng Gao, Atsuko Yonemura, Luke Bu, Hirohisa Okabe, et al. Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas. Oncogene. 2019. 38. 8. 1211-1224
Takashi Matsumoto, Hirohisa Okabe, Yo-Ichi Yamashita, Toshihiko Yusa, Rumi Itoyama, Yosuke Nakao, Takanobu Yamao, Naoki Umzaki, Masayo Tsukamoto, Yuki Kitano, et al. Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors. Surgery today. 2019. 49. 1. 21-26
Akira Watanabe, Norifumi Harimoto, Kenichiro Araki, Tomoharu Yoshizumi, Kota Arima, Yoichi Yamashita, Hideo Baba, Higuchi Tetsuya, Hiroyuki Kuwano, Ken Shirabe. A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer. Journal of surgical oncology. 2018. 118. 7. 1088-1095
Shigeki Nakagawa, Hirohisa Okabe, Mayuko Ouchi, Ryuma Tokunaga, Naoki Umezaki, Takaaki Higashi, Takatoshi Kaida, Kota Arima, Yuki Kitano, Hideyuki Kuroki, et al. Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2018. 20. 10. 939-948
Tsugio Eto, Keisuke Miyake, Katsuhiko Nosho, Masaki Ohmuraya, Yu Imamura, Kota Arima, Shinichi Kanno, Lingfeng Fu, Yuki Kiyozumi, Daisuke Izumi, et al. Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression. The Journal of pathology. 2018. 245. 4. 445-455

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page